Excellent lithium responders have normal cognitive functions and plasma BDNF levels

International Journal of Neuropsychopharmacology

Volumn 13, Issue 5, 2010, Pages 617-622

  Rybakowski, Janusz K ^a   Suwalska, Aleksandra ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Brain derived neurotrophic factor; Cognitive function; Excellent lithium responders; Lithium

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM CARBONATE;

ADULT; AGED; APTITUDE TEST; ARTICLE; ATTENTION; BIPOLAR DISORDER; COGNITION; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REMISSION; WORKING MEMORY;

ADULT; AGED; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 77953501147     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000404     Document Type: Article

References (19)

1. Cunha AB, Frey BN, Andreazza AC, Goi JD, et al. (2006). Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters 398, 215-219.
2. First M, Spitzer R, Gibbon M, Williams J (1997). Structured Clinical Interview for DSM-IV Axis I disorders, research version. New York: Biometrics Research.
3. Goldberg JF, Chengappa KN (2009). Indentifying and treating cognitive impairment in bipolar disorder. Bipolar Disorders 11 (Suppl. 2), 12-137.
4. Grof P (1999). Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW (Eds), Lithium: 50 Years of Psychopharmacology, New Perspectives in Biomedical and Clinical Research (pp. 36-51). Cheshire, Connecticut: Weidner Publishing Group.
5. Grof P (in press). Sixty years of lithium responders. Neuropsychobiology.
6. Hamilton M (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23, 56-62.
7. Hartigan G (1963). The use of lithium salts in affective disorders. British Journal of Psychiatry 109, 810-814.
8. KapczinskiF,Fernandes BS, Kauer-Sant'AnnaM,Gama CS, et al. (2009). The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers. Acta Neuropsychiatrica 21, 272-274.
9. Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, et al. (2007). Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biological Psychiatry 61, 142-144.
10. Martinez-Aran A, Vieta E, Reinares M, Colom F, et al. (2004). Cognitive functions across manic or hypomanic, depressed, and euthymic states in bipolar disorder. American Journal of Psychiatry 161, 262-270.
11. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, et al. (2007). Persistent neuropsychological deficit in euthymic bipolar patients: executive function as core deficit. Journal of Clinical Psychiatry 68, 1078-1086.
12. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, et al. (2008). Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. Journal of Clinical Psychiatry 69, 712-719.
13. Post RM (2007). Role of bDNF in bipolar and unipolar disorder: clinical and theoretical implications. Journal of Psychiatric Research 41, 979-990.
14. Robbins TW, James M, Owen AM, Sahakian BJ, et al. (1994). Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia and Geriatric Cognitive Disorders 5, 266-281.
15. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A (2001). The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disorders 3, 63-67.
16. Rybakowski JK, Permoda-Osip A, Borkowska A (2009). Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. European Neuropsychopharmacology 19, 791-795.
17. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, et al. (2005). Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 38, 166-170. (Pubitemid 41059223)
18. Tramontina JF, Andreazza AC, Kauer-Sant'anna M, Stertz L, et al. (2009). Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neuroscience Letters 452, 111-113.
19. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.